BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32317795)

  • 21. Orbital and optic pathway sarcoidosis: MR findings.
    Carmody RF; Mafee MF; Goodwin JA; Small K; Haery C
    AJNR Am J Neuroradiol; 1994 Apr; 15(4):775-83. PubMed ID: 8010282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral lacrimal gland disease: clinical features and outcomes.
    Huang S; Juniat V; Satchi K; Cohen LM; Davis G; Rootman DB; McNab A; Selva D
    Eye (Lond); 2022 Nov; 36(11):2163-2171. PubMed ID: 34725471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Imaging Features of Lacrimal Gland Involvement in Granulomatosis with Polyangiitis.
    Tan LT; Davagnanam I; Isa H; Rose GE; Verity DH; Pusey CD; Lightman S
    Ophthalmology; 2015 Oct; 122(10):2125-9. PubMed ID: 26233627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of different orbital manifestations of granulomatosis with polyangiitis.
    Ismailova DS; Abramova JV; Novikov PI; Grusha YO
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1751-1756. PubMed ID: 29846785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcoidosis-related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis.
    Ma SP; Rogers SL; Hall AJ; Hodgson L; Brennan J; Stawell RJ; Lim LL
    Am J Ophthalmol; 2019 Feb; 198():30-36. PubMed ID: 30243930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Orbital sarcoidosis--a case with an unusual course].
    Auw-Hädrich C; Gerling J; Witschel H
    Klin Monbl Augenheilkd; 1998 Mar; 212(3):181-3. PubMed ID: 9592747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orbital granuloma annulare as presentation of systemic sarcoidosis.
    Kang JJ; Aakalu VK; Lin A; Setabutr P
    Orbit; 2013 Dec; 32(6):372-4. PubMed ID: 23895369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australasian orbital and adnexal Wegener's granulomatosis.
    Woo TL; Francis IC; Wilcsek GA; Coroneo MT; McNab AA; Sullivan TJ;
    Ophthalmology; 2001 Sep; 108(9):1535-43. PubMed ID: 11535446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement.
    Tan LT; Davagnanam I; Isa H; Taylor SR; Rose GE; Verity DH; Pusey CD; Lightman S
    Ophthalmology; 2014 Jun; 121(6):1304-9. PubMed ID: 24560566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orbital sarcoidosis presenting as diffuse swelling of the lower eyelid.
    Lee JK; Moon NJ
    Korean J Ophthalmol; 2013 Feb; 27(1):52-4. PubMed ID: 23372381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome.
    Leibovitch I; Selva D; Goldberg RA; Sullivan TJ; Saeed P; Davis G; McCann JD; McNab A; Rootman J
    Ophthalmology; 2006 Sep; 113(9):1657-64. PubMed ID: 16828514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of orbital decompression on diplopia in thyroid-related orbitopathy.
    Mainville NP; Jordan DR
    Ophthalmic Plast Reconstr Surg; 2014; 30(2):137-40. PubMed ID: 24481502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilaterally Diffuse Lacrimal Gland Involvement: Initial Presentation of Systemic Sarcoidosis.
    Bingöl Kızıltunç P; Çiftçi F; Hoşal B; Kaygusuz G
    Turk J Ophthalmol; 2017 Jun; 47(3):165-168. PubMed ID: 28630793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic medial orbital fat decompression for proptosis in type 1 graves orbitopathy.
    Wu W; Selva D; Bian Y; Wang X; Sun MT; Kong Q; Yan W
    Am J Ophthalmol; 2015 Feb; 159(2):277-84. PubMed ID: 25448997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic sarcoidosis with bilateral orbital involvement: MR findings.
    Simon EM; Zoarski GH; Rothman MI; Numaguchi Y; Zagardo MT; Mathis JM
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):336-7. PubMed ID: 9504490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic granulomatous orbital inflammation.
    Mombaerts I; Schlingemann RO; Goldschmeding R; Koornneef L
    Ophthalmology; 1996 Dec; 103(12):2135-41. PubMed ID: 9003349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of orbital fat decompression in Graves' orbitopathy.
    Cheng AM; Wei YH; Tighe S; Sheha H; Liao SL
    Br J Ophthalmol; 2018 Jan; 102(1):69-73. PubMed ID: 28450378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.